VM 206
/ Helixmith
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 08, 2013
Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer
(clinicaltrials.gov)
- P1; N=9; Completed; Sponsor: Reyon Pharmaceutical Co., Ltd.
Clinical • New P1 trial
October 21, 2013
Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer
(clinicaltrials.gov)
- P1; N=9; Completed; Sponsor: Reyon Pharmaceutical Co., Ltd.; Terminated ➔ Completed
Clinical • Trial completion
1 to 2
Of
2
Go to page
1